Specifically, MD compliance was independently associated with patients’ BMI and WHR, disease disability expressed by EDSS, physical activity classified by IPAQ, quality of life of MS patients categorized by MSQOL-54, depression assessed by BDI-II and blood circulating albumin, RBC, hemoglobin, and hematocrit levels (Table 3, p < 0.05). The gene discussed is ALB; the disease is myeloid sarcoma.